Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [12613]

$European Commission grants marketing authorization for lenvatinib in advanced RAI-refractory differentiated thyroid cancer$

European Commission grants marketing authorization for lenvatinib in advanced RAI-refractory differentiated...

NICE preliminary decision to remove olaparib for ovarian cancer patients with BRCA gene mutations

NICE preliminary decision to remove olaparib for ovarian cancer patients with BRCA gene mutations

Western diet after prostate cancer diagnosis associated with increased risk of death

Western diet after prostate cancer diagnosis associated with increased risk of death

ASCO 2015: MEDI4736 tremelimumab combo shows activity in NSCLC

ASCO 2015: MEDI4736 tremelimumab combo shows activity in NSCLC

ASCO 2015: Phase III study finds initial nivolumab-based treatment halts melanoma progression

ASCO 2015: Phase III study finds initial nivolumab-based treatment halts melanoma progression

ASCO 2015: Improved care has extended the lifespan of childhood cancer survivors since the 1970s

ASCO 2015: Improved care has extended the lifespan of childhood cancer survivors since the 1970s

ASCO 2015: Preventive neck lymph node surgery improves early oral cancer survival

ASCO 2015: Preventive neck lymph node surgery improves early oral cancer survival

ASCO 2015: Risks of adjuvant whole brain radiation therapy outweigh benefits for patients with limited brain metastases

ASCO 2015: Risks of adjuvant whole brain radiation therapy outweigh benefits for patients with limited brain...

ASCO 2015: First effective adjuvant chemotherapy for high-risk, localised prostate cancer

ASCO 2015: First effective adjuvant chemotherapy for high-risk, localised prostate cancer

ASCO 2015: Extensive lymph node surgery may not be necessary for some patients with melanoma

ASCO 2015: Extensive lymph node surgery may not be necessary for some patients with melanoma

More from ecancer